EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Tyrosine Kinase Inhibitor Induced Proteinuria – A Review

J S Gayathri, S Swathi Krishna, M P Rakesh

Drug Research · 01.01.2025 · 75 (01) · 5-11

DOI: 10.1055/a-2423-3533 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Research, erschienen am 01.01.2025. Verfasst von J S Gayathri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Health Science Campus, Amrita Vishwa Vidyapeetham, Ponekkara, Kochi, India. Hauptthemen laut MEDLINE: Proteinuria, Protein Kinase Inhibitors, Protein-Tyrosine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine Kinase inhibitor (TKI) is a class of drugs that interfere with protein kinasesʼ signal transduction pathways through an array of inhibitory mechanisms. Tyrosine kinases (TK) have an inevitable role in downstream signal transduction and the proliferation of tumour cells. Hence, tyrosine kinase inhibitors (TKIs) are frequently employed as anti-neoplastic agents in the treatment of colon, breast, kidney, and lung cancers. They can be used as single or combination therapy with other targeted therapies. It is understood that TKIs pose a risk of developing proteinuria in some patients as it can primarily result in dysfunction of the split diaphragm, constriction or blockage of capillary lumens mediated by the basement membrane, acute interstitial nephritis, or acute tubular necrosis. This paper reviews the mechanism of action of TKIs, the pathophysiological mechanism of TKI-induced proteinuria, and its management Fig. 1

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteinuriaProtein Kinase InhibitorsProtein-Tyrosine KinasesHumansAntineoplastic AgentsAnimalsSignal TransductionNeoplasmsTyrosine Kinase Inhibitors

Substanzen

Protein Kinase InhibitorsProtein-Tyrosine KinasesAntineoplastic AgentsTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Health Science Campus, Amrita Vishwa Vidyapeetham, Ponekkara, Kochi, India.
  • Department of Medical Oncology, Amrita Health Science Campus, Amrita Vishwa Vidyapeetham, Ponekkara, Kochi, India.

Zitieren

APA

Gayathri, J. S., Krishna, S. S., & Rakesh, M. P. (2025). Tyrosine Kinase Inhibitor Induced Proteinuria – A Review. Drug Research, 75(01), 5-11. https://doi.org/10.1055/a-2423-3533

Vancouver

Gayathri JS, Krishna SS, Rakesh MP. Tyrosine Kinase Inhibitor Induced Proteinuria – A Review. Drug Research. 2025;75(01):5-11. doi:10.1055/a-2423-3533

BibTeX
@article{Gayathri2025,
  author = {Gayathri, J S and Krishna, S Swathi and Rakesh, M P},
  title = {Tyrosine Kinase Inhibitor Induced Proteinuria – A Review},
  journal = {Drug Research},
  year = {2025},
  volume = {75},
  number = {01},
  pages = {5--11},
  doi = {10.1055/a-2423-3533}
}
Kostenlos starten →